Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.50 |
| ▸ | ECE1 | P42892 | 1/20 | 0.50 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 4/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | KDM5C | P41229 | 3/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10033437 | 0.87 | PHF8 (0.46) | LDHASRRECE1EGLN1LMNA | |
| SCHEMBL16687527 | 0.87 | ECE1 (0.41) | LDHASRRECE1EGLN1LMNA | |
| SCHEMBL10033458 | 0.87 | KDM4E (0.50) | LDHASRRECE1LMNAKDM4E | |
| SCHEMBL4579273 | 0.85 | ECE1 (0.44) | LDHASRRECE1EGLN1PHF8 | |
| SCHEMBL2554103 | 0.85 | ECE1 (0.44) | LDHASRRECE1ALDH1A1MEN1 | |
| SCHEMBL27858651 | 0.85 | ECE1 (0.70) | LDHASRRECE1EGLN1LMNA | |
| SCHEMBL2554762 | 0.83 | ECE1 (0.43) | LDHASRRECE1LMNAPHF8 | |
| SCHEMBL15601857 | 0.83 | MCL1 (0.52) | LDHASRRECE1LMNAMEN1 | |
| SCHEMBL8413493 | 0.83 | HDAC3 (0.52) | LDHASRRECE1FOLH1ALDH1A1 | |
| SCHEMBL11921768 | 0.80 | LDHA (0.50) | LDHASRRECE1EGLN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110316926-A1 | Organic Phase Change Carriers Containing Nanoparticles, Phase Change Inks Including Same and Methods for Making Same | XEROX CORPORATION (US) | 2011-12-29 | — | — | US | disclosed |
| US-20100116424-A1 | ORGANIC PHASE CHANGE CARRIERS CONTAINING NANOPARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME | XEROX CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-7714040-B2 | Phase change inks containing curable amide gellant compounds | XEROX CORPORATION (US) | 2010-05-11 | — | — | US | disclosed |
| US-7699922-B2 | Organic phase change carriers containing nanoparticles, phase change inks including same and methods for making same | XEROX CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-7625956-B2 | Phase change inks containing photoinitiator with phase change properties and gellant affinity | XEROX CORPORATION (US) | 2009-12-01 | — | — | US | disclosed |
| US-20070283846-A1 | Organic Phase Change Carriers Containing Nanoparticles, Phase Change Inks Including Same and Methods for Making Same | XEROX CORPORATION (US) | 2007-12-13 | — | — | US | disclosed |
| US-7279587-B2 | Photoinitiator with phase change properties and gellant affinity | XEROX CORPORATION (US) | 2007-10-09 | — | — | US | disclosed |
| US-7276614-B2 | Curable amide gellant compounds | XEROX CORPORATION (US) | 2007-10-02 | — | — | US | disclosed |
| US-7259275-B2 | Method for preparing curable amide gellant compounds | XEROX CORPORATION (US) | 2007-08-21 | — | — | US | disclosed |
| US-20070123606-A1 | Phase change inks containing curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123724-A1 | Method for preparing curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123723-A1 | Photoinitiator with phase change properties and gellant affinity | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123722-A1 | Ester-terminated oligoamides and polyamides having terminal ethylenic double bonds; gelling agents for phase change ink jet inks with improved ultraviolet curability and solubility | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120910-A1 | Phase change inks containing photoinitiator with phase change properties and gellant affinity | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123724-A1 | Method for preparing curable amide gellant compounds | ODC1, INO80C, AOC1 | LDHA 3100/4885SRR 2499/4885ECE1 1425/4885 |
| US-20070123723-A1 | Photoinitiator with phase change properties and gellant affinity | NR2E3, NR4A1, NR4A3 | LDHA 4288/4885SRR 641/4885ECE1 2542/4885 |
| US-20070123722-A1 | Ester-terminated oligoamides and polyamides having terminal ethylenic double bonds; gelling agents for phase change ink jet inks with improved ultraviolet curability and solubility | CCNA2, ELL, CCNA1 | LDHA 4749/4885SRR 2895/4885ECE1 355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.